George Church is "thinking a lot about using regeneration as the key to treatments and keeping people healthy," as he tells David Ewing Duncan at Technology Review's Experimental Man. Induced pluripotent stem cells "is where I'm putting almost all of my chips these days, because it combines many of my interests — genomics, sequencing, epigenetics, synthetic biology, stem cells," Church adds.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Hundreds of scientists have signed a letter criticizing the open-access Plan S, ScienceInsider reports.

A start-up company aiming to match cancer patients to treatments closes after about six weeks, Stat News reports.

NPR speaks with Rep. Eddie Bernice Johnson (D-Texas) about the US House of Representatives science committee.

In PLOS this week: somatic mutation associations unearthed in thousands of cancer exomes, pathogen detection assay, and more.